Immunovant
IMVT
IMVT
24 hedge funds and large institutions have $176M invested in Immunovant in 2019 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Holders
24
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$66M | |
| 2 | +$16.2M | |
| 3 | +$15.8M | |
| 4 |
GTC
Ghost Tree Capital
New York
|
+$12.7M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$9.85M |
Top Sellers
| 1 | -$12.5M | |
| 2 | -$8.21M | |
| 3 | -$5.58M | |
| 4 |
DKCM
Davidson Kempner Capital Management
New York
|
-$5.13M |
| 5 |
JGC
J. Goldman & Co
New York
|
-$3.01M |